Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

NCT00019773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Carcinoma of the Appendix
Colorectal Cancer
Small Intestine Cancer

Interventions

DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

National Cancer Institute (NCI)